Dianosic has been selected by Challenges magazine as one of the 100 innovative startups where it is worth to invest in 2021 ! Learn more : “Dianosic : innovations disruptives pour les affections ORL”
Share this article
Challenges – Dianosic has been selected among the 100 most innovative startups to invest in 2021
Discover our other articles
Discover the article: Dianosic plans to raise EUR 10m in Series A; to seek exit sale around 2026 – CEO
Dianosic raises €4.7M to bring treatment for chronic rhinitis into clinical trial. ▶︎ Click here to discover the press release. Pr. Christian…
Dianosic laureate of the i-Lab 2019 innovation contest The jury of the prestigious “i-Lab” innovation contest, organized by the Ministère de l’Enseignement Supérieur…
